These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7949134)

  • 1. Absence of WAF1 mutations in a variety of human malignancies.
    Shiohara M; el-Deiry WS; Wada M; Nakamaki T; Takeuchi S; Yang R; Chen DL; Vogelstein B; Koeffler HP
    Blood; 1994 Dec; 84(11):3781-4. PubMed ID: 7949134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of the p21/WAF1/CIP1/SDI1 coding region in human tumor cell lines.
    Terry LA; Boyd J; Alcorta D; Lyon T; Solomon G; Hannon G; Berchuck A; Beach D; Barrett JC
    Mol Carcinog; 1996 Aug; 16(4):221-8. PubMed ID: 8784465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.
    Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF
    Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer.
    Li YJ; Laurent-Puig P; Salmon RJ; Thomas G; Hamelin R
    Oncogene; 1995 Feb; 10(3):599-601. PubMed ID: 7845685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
    Shi Y; Zou M; Farid NR; al-Sedairy ST
    Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas.
    Vidal MJ; Loganzo F; de Oliveira AR; Hayward NK; Albino AP
    Melanoma Res; 1995 Aug; 5(4):243-50. PubMed ID: 7496159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of a mutation of the p21/WAF1 gene in human lung and pancreatic cancers.
    Shimizu T; Miwa W; Nakamori S; Ishikawa O; Konishi Y; Sekiya T
    Jpn J Cancer Res; 1996 Mar; 87(3):275-8. PubMed ID: 8613430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours.
    Koopmann J; Maintz D; Schild S; Schramm J; Louis DN; Wiestler OD; von Deimling A
    Br J Cancer; 1995 Nov; 72(5):1230-3. PubMed ID: 7577473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations.
    McKenzie KE; Siva A; Maier S; Runnebaum IB; Seshadri R; Sukumar S
    Clin Cancer Res; 1997 Sep; 3(9):1669-73. PubMed ID: 9815858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
    Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between human cancer and two polymorphisms occurring together in the p21Waf1/Cip1 cyclin-dependent kinase inhibitor gene.
    Facher EA; Becich MJ; Deka A; Law JC
    Cancer; 1997 Jun; 79(12):2424-9. PubMed ID: 9191533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of mutation in the WAF1/CIP1 gene during bovine leukemia virus-induced leukemogenesis.
    Dequiedt F; Willems L; Kerkhofs P; Burny A; Kettmann R
    Vet Immunol Immunopathol; 1997 Nov; 59(3-4):311-22. PubMed ID: 9477480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1.
    Chedid M; Michieli P; Lengel C; Huppi K; Givol D
    Oncogene; 1994 Oct; 9(10):3021-4. PubMed ID: 8084608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations.
    Ozçelik H; Mousses S; Andrulis IL
    Clin Cancer Res; 1995 Aug; 1(8):907-12. PubMed ID: 9816061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function.
    Chilosi M; Doglioni C; Magalini A; Inghirami G; Krampera M; Nadali G; Rahal D; Pedron S; Benedetti A; Scardoni M; Macrì E; Lestani M; Menestrina F; Pizzolo G; Scarpa A
    Blood; 1996 Nov; 88(10):4012-20. PubMed ID: 8916968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient repair of bulky anti-BPDE DNA adducts from non-transcribed DNA strand requires functional p53 but not p21(waf1/cip1) and pRb.
    Wani MA; El-Mahdy MA; Hamada FM; Wani G; Zhu Q; Wang QE; Wani AA
    Mutat Res; 2002 Aug; 505(1-2):13-25. PubMed ID: 12175902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of p53 and expression of WAF1/p21 in human thyroid tumors.
    Zedenius J; Larsson C; Wallin G; Bäckdahl M; Aspenblad U; Höög A; Børresen AL; Auer G
    Thyroid; 1996 Feb; 6(1):1-9. PubMed ID: 8777377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
    Kralj M; Husnjak K; Körbler T; Pavelić J
    Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.